Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acer Therapeutics Inc (NASDAQ:ACER)

17.43
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
5.70
Today|||52-Week Range
22.63
+82.94%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close17.43
Today’s open16.50
Day’s range16.50 - 17.61
Volume8,416
Average volume (3 months)21,109
Market cap$112.4M
Dividend yield--
Data as of 3:55pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+44.88%
Earnings growth (this year)+58.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.65%
P/E ratioNM
Price/Sales2.23
Price/Book4.44

Competitors

 Today’s
change
Today’s
% change
NEOTNeothetics Inc0.000.00%
--Achieve Life Science...-0.20-11.40%
MBVXMabVax Therapeutics ...0.000.00%
CPHIChina Pharma Holding...0.000.00%
Data as of 4:00pm ET, 11/22/2017

Financials

Last reporting dateNovember 13, 2017
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$2.9M
Annual profit (last year)-$8.0M
Net profit margin-274.69%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Cambridge, Massachusetts

Forecasts